Hector Ventura, MD, FACC, FACP
- Sr Physician-Vice Chair, Southshore Region
- 1514 Jefferson Hwy, New Orleans, LA, 70121
For additional information or to make an appointment, click here.
Overview
Overview
- Dr. Hector Ventura earned his medical degree from the National University School of Medicine in Buenos Aires, Argentina. After completing a residency at the Central Military Hospital in Buenos Aires, he completed an internship and residency at Ochsner where he also completed fellowships in arterial hypertension and cardiovascular diseases. He also completed a fellowship in heart failure and transplantation at Loyola University in Chicago, Illinois. Dr. Ventura has served in his current position at Ochsner since the year 2000. He is board-certified in cardiology and has a wide range of special expertise including the history of medicine. He has written numerous articles for scientific medical publications and serves on several editorial boards of medical journals and is the Associate Editor for Congestive Heart Failure.
Publications
Selected publications
-
2023Association of Glucosamine Supplementation and Incidence of Heart Failure. Mayo Clinic Proceedings. 98:1118-1120.
-
2023Preimplant Hyponatremia Does Not Predict Adverse Outcomes in Patients With Left Ventricular Assist Devices. Current Problems in Cardiology. 48.
-
2023Angiotensin-Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 82:13-15.
-
2023Updates on obesity and the obesity paradox in cardiovascular diseases. Progress in Cardiovascular Diseases. 78:2-10.
-
2023The value of frequent objective risk assessments in heart failure management. International Journal of Cardiology. 379:100-101.
-
2023Optimal Prevention of Cardiovascular Diseases The Earlier the Better. Journal of the American College of Cardiology. 81:1162-1164.
-
2023Trends in Heart Failure Outcomes From a Large, Geographically Diverse Cohort During the COVID-19 Pandemic. Mayo Clinic Proceedings. 98:4-6.
-
2022Optimized dosing of guideline-directed medical therapies is essential in heart failure with reduced ejection fraction. International Journal of Cardiology. 370:325-326.
-
2022Biomarkers in heart failure: Relevance in the clinical practice. International Journal of Cardiology. 363:196-201.
-
2022Feasibility and Safety of Coronary Angiography via Radial Approach in Cardiac Transplant Recipients: A Single Center Experience. Current Problems in Cardiology. 47.
-
2022Triple Antithrombotic Therapy in Patients With Left Ventricular Assist Devices. Current Problems in Cardiology. 47.
-
2022Impact of trends in body mass index on outcomes in patients receiving HeartMate 3. European Journal of Heart Failure. 24:150-150.
-
2022Understanding Heart Failure Risk in a Diverse Cohort With Human Immunodeficiency Virus Infection (vol 97, pg 433, 2022). Mayo Clinic Proceedings. 97:1217-1217.
-
2022Hyponatremia Does Not Predict Adverse Outcomes In Patient With Left Ventricular Assist Devices. Journal of Cardiac Failure. 28:S67-S68.
-
2022Outcomes Of Intermittent Hemodialysis During Support With Ventricular Assist Devices: A Potential Bridge To Heart/kidney Transplantation?. Journal of Cardiac Failure. 28:S18-S19.
-
2022Short-term Outcomes Of Intermittent Hemodialysis In Patients With Ventricular Assist Devices. Journal of Cardiac Failure. 28:S27-S28.
-
2022Understanding Heart Failure Risk in a Diverse Cohort With Human Immunodeficiency Virus Infection. Mayo Clinic Proceedings. 97:433-435.
-
2021Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the TOSCA. Registry. European Journal of Preventive Cardiology. 28:1691-1700.
-
2021Second Consensus on Treatment of Patients Recently Diagnosed with Mild Hypertension and Low Cardiovascular Risk (vol 45, 100653, 2020). Current Problems in Cardiology. 46.
-
2021Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes in COVID-19 Infection. Current Problems in Cardiology. 46.
-
2021FGF23 predicts outcomes in heart failure but questions remain unanswered. International Journal of Cardiology. 338:145-146.
-
2021Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure. Current Opinion in Cardiology. 36:453-460.
-
2021New aspects in the management of hypertension in the digital era. Current Opinion in Cardiology. 36:398-404.
-
2021Prognostic value of cardiopulmonary exercise test after heart transplantation. Clinical Transplantation.
-
2021IMPACT OF BASELINE LEFT VENTRICULAR EJECTION FRACTION ON OUTCOMES IN COVID-19 INFECTION. Journal of the American College of Cardiology. 77:3066-3066.
-
2021Preoperative Body Mass Index < 45 Kg/m(2) Predicts Clinical Success after Bariatric Surgery in Patients with Ventricular Assist Devices. Journal of Heart and Lung Transplantation. 40:S414-S414.
-
2020BMI Trends In Patients With Ventricular Assist Devices After Bariatric Surgery. Journal of Cardiac Failure. 26:S40-S41.
-
2020Bariatric Surgery In Obese Patients With Ventricular Assist Devices: A Single Center Experience. Journal of Cardiac Failure. 26:S43-S43.
-
2020Outcomes After Bariatric Surgery In Patients With Ventricular Assist Devices: Systematic Review And Individual Participant Data Meta-analysis. Journal of Cardiac Failure. 26:S53-S53.
-
2020Ruptured Bullae: A Rare Cause of No-flow Alarms In Ventricular Assist Devices. Journal of Cardiac Failure. 26:S62-S62.
-
2020Editorial: Hypertension in special populations and the role in comoborbities. Current Opinion in Cardiology. 35:341-341.
-
2020Heart Failure With Preserved Ejection Fraction Separating the Wheat From the Chaff. Journal of the American College of Cardiology. 75:255-257.
-
2020Heart Failure With Preserved Ejection Fraction The Quest for a Blood Pressure Goal. Journal of the American College of Cardiology. 75:1657-1658.
-
2020Managing the complexities of cardiac amyloidosis: a path for success. European Journal of Preventive Cardiology.
-
2020POGO STICKING AND LVAD SQUEAKING! TORSION OF A HEARTMATE 3 OUTFLOW CANNULA AFTER JUMPING ON A POGO STICK. Journal of the American College of Cardiology. 75:3344-3344.
-
2020When good intentions turn bad: A need for course correction. Journal of Heart and Lung Transplantation. 39:5-6.
-
2019An update on pharmacotherapies in diabetic dyslipidemia. Progress in Cardiovascular Diseases. 62:334-341.
-
2019Diabetic cardiomyopathy - A comprehensive updated review. Progress in Cardiovascular Diseases. 62:315-326.
-
2019Editor Message. Current Problems in Cardiology. 44.
-
2019Editor Message. Current Problems in Cardiology. 44.
-
2019Editor Message. Current Problems in Cardiology. 44.
-
2019Edward D. Frohlich, MD September 10, 1931-August 16, 2019 In Memoriam. Hypertension. 74:1229-1231.
-
2019HDL and Heart Failure Regulation Still Breathing but Exhausted. Journal of the American College of Cardiology. 73:187-189.
-
2019LVAD as Bridge to Transplant Leads to Better Outcomes When Compared to Transplant-Only Strategy. Journal of Cardiac Failure. 25:S169-S169.
-
2019Left Ventricular Assist Devices vs. Cardiac Transplantation: The Age Factor. Journal of Cardiac Failure. 25:S169-S170.
-
2019New Guidelines, Increasing Hypertension Numbers, Resistance and Resistance to Change?. Mayo Clinic Proceedings. 94:745-747.
-
2019Rabbit Anti-Thytnocyte Globulin (rATG) Induction in Heart Transplant Recipients at High Risk for Rejection.. American Journal of Transplantation. 19:784-785.
-
2018Blood pressure and goal titration of neurohormonal antagonists: the tortoise wins again?. European Journal of Heart Failure. 20:501-503.
-
2018Blood pressure measurements for treating hypertension: which method counts the most?. Heart. 104:1142-1143.
-
2018Cardiovascular disease burden in cancer patients from 2003 to 2014. European Heart Journal - Quality of Care and Clinical Outcomes. 4:69-70.
-
2018
-
2018John Lockwood Ochsner: Celebration of life OBITUARY. The Journal of Thoracic and Cardiovascular Surgery. 156:1769-1771.
-
2018Management of cardiovascular diseases in patients with obesity. Nature Reviews Cardiology. 15:45-56.
-
2018Muscling up to improve heart failure prognosis. European Journal of Heart Failure. 20:1588-1590.
-
2018Obesity and Prognosis in Pediatric Dilated Cardiomyopathy No Paradox or Adverse Effects. JACC: Heart Failure. 6:231-232.
-
2018Prognostic Implications of Left Ventricular Hypertrophy. Progress in Cardiovascular Diseases. 61:446-455.
-
2018Psychopharmacology and Cardiovascular Disease. Journal of the American College of Cardiology. 71:2346-2359.
-
2018Rehabilitating cardiac rehabilitation after heart transplantation. Journal of Heart and Lung Transplantation. 37:437-438.
-
2018The Impact of Mediators of Health Literacy on Clinical Outcomes in Cardiovascular Diseases. Mayo Clinic Proceedings. 93:1700-1702.
-
2018The check list manifesto for mechanical circulatory support: Targeting anti-coagulation efficiency. Journal of Heart and Lung Transplantation. 37:568-569.
-
2017Adipose Composition and Heart Failure Prognosis Paradox or Not?. Journal of the American College of Cardiology. 70:2750-2751.
-
2017Changing our Approach to Stage D Heart Failure. Progress in Cardiovascular Diseases. 60:205-214.
-
2017Clinical Perspective on Anti hypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation. Current Problems in Cardiology. 42:198-225.
-
2017HYPERTENSION CONTROL IS STRONGLY INFLUENCED BY PATIENT'S HEALTH CAPABILITY. Journal of the American College of Cardiology. 69:1838-1838.
-
2017Hemodynamic effects of a fully magnetically levitated centrifugal-flow left ventricular assist device. Journal of Heart and Lung Transplantation. 36:19-21.
-
2017Hypertension in Patients with Cardiac Transplantation. Medical Clinics of North America. 101:53.
-
2017Improving Hypertension Control and Patient Engagement Using Digital Tools. American Journal of Medicine. 130:14-20.
-
2017Observations and Reflections on the Burden of Hospitalizations for Heart Failure. Mayo Clinic Proceedings. 92:175-178.
-
2017Observations on the blood pressure paradox in heart failure. European Journal of Heart Failure. 19:843-845.
-
2017Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice. Progress in Cardiovascular Diseases. 60:187-197.
-
2017The Interaction of Cardiorespiratory Fitness With Obesity and the Obesity Paradox in Cardiovascular Disease. Progress in Cardiovascular Diseases. 60:30-44.
-
2017The importance of achieving blood pressure control, what is the target?. Current Opinion in Cardiology. 32:363.
-
2017Therapeutic Cardiorespiratory Fitness to Prevent and Treat eart Failure. JACC: Heart Failure. 5:375-376.
-
2017Use of Gene Expression Profiling Score Variability to Predict Cardiac Allograft Vasculopathy: A Single Center Experience. Journal of Heart and Lung Transplantation. 36:S295-S295.
-
2016Body Composition and Advanced Heart Failure Therapy Weighing the Options and Outcomes. JACC: Heart Failure. 4:769-771.
-
2016Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox. Future Cardiology. 12:639-653.
-
2016Breaking Down the Barriers: Why the Delay in Referral for Pulmonary Arterial Hypertension?. The Ochsner Journal. 16:257-262.
-
2016Current Perspectives on Left Ventricular Geometry in Systemic Hypertension. Progress in Cardiovascular Diseases. 59:235-246.
-
2016Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial. European Journal of Heart Failure. 18:1072-1081.
-
2016Gaining a new skill: Radial catheterization Foreword. Current Problems in Cardiology. 41:193-193.
-
2016Genotype and Phenotype of Transthyretin Cardiac Amyloidosis THAOS (Transthyretin Amyloid Outcome Survey). Journal of the American College of Cardiology. 68:161-172.
-
2016Impact of Obesity on the Prevalence and Prognosis of Heart Failure-It Is Not Always Just Black and White. Journal of Cardiac Failure. 22:598-599.
-
2016Influence of Neurohormonal Antagonists on the Association of Loop Diuretic Dose with Mortality in Patients with Heart Failure: Insights From the UNITE-HF Registry. Journal of Cardiac Failure. 22:S35-S35.
-
2016New Concepts in Hypertension Management: A Population-Based Perspective. Progress in Cardiovascular Diseases. 59:289-294.
-
2016Obesity Cardiomyopathy: Pathophysiologic Factors and Nosologic Reevaluation. The American Journal of the Medical Sciences. 352:219-222.
-
2016REPLY: The "Obesity Paradox" Is Not a Paradox: Time to Focus on Effective Treatments. JACC: Heart Failure. 4:234-235.
-
2016Tackling cardiovascular disease in Hispanic/Latinos: Achieving 2020 Goals. American Heart Journal. 176:125-126.
-
2016The Secret Trip of Dr Alton Ochsner. The Ochsner Journal. 16:116-119.
-
2016Triple Antithrombotic Therapy in Patients with Left Ventricular Assist Devices: A Single Center Experience. Journal of Heart and Lung Transplantation. 35:S250-S251.
-
2016Update on Obesity and Obesity Paradox in Heart Failure. Progress in Cardiovascular Diseases. 58:393-400.
-
2015Clinical Profiles and Outcomes of Cardiac Transplant Recipients Using Allomap and Cylex Immuknow Assays. Journal of Heart and Lung Transplantation. 34:S295-S295.
-
2015Critical impact of fitness in the prevention and treatment of heart failure. American Heart Journal. 169:194-196.
-
2015Impact of Ethnicity and Race on Response to Angiotensin-Converting Enzyme Inhibitors in Heart Failure. Journal of Cardiac Failure. 21:457-459.
-
2015Management of Patients Admitted with Acute Decompensated Heart Failure. The Ochsner Journal. 15:284-289.
-
2015PROPHYLACTIC INTRA-AORTIC BALLOON PUMP INSERTION PRIOR TO SURGICAL LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION. Journal of the American College of Cardiology. 65:A889-A889.
-
2015Pulmonary Arterial Hypertension and the Failing Ventricle: Getting It Right. Cardiovascular Innovations and Applications. 1:81-91.
-
2015Quantity, but More Important, Quality of Life in Heart Failure. The Ochsner Journal. 15:216-216.
-
2015Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry. Journal of Heart and Lung Transplantation. 34:912-920.
-
2015The Obesity Paradox in Heart Failure Is it All About Fitness, Fat, or Sex?. JACC: Heart Failure. 3:927-930.
-
2014B-Type Natriuretic Peptide Profiles in the Setting of Chronic Left Ventricular Assist Device Support. Journal of Heart and Lung Transplantation. 33:S236-S236.
-
2014BODY COMPOSITION AND SURVIVAL IN PATIENTS WITH SYSTOLIC HEART FAILURE AND UNDERLYING CORONARY HEART DISEASE. Journal of the American College of Cardiology. 63:A936-A936.
-
2014Blood Pressure Profiles of Patients with Left Ventricular Assist Devices. Journal of Heart and Lung Transplantation. 33:S217-S217.
-
2014CORRELATION BETWEEN B-TYPE NATRIURETIC PEPTIDE LEVELS AND PULMONARY CAPILLARY WEDGE PRESSURE IN PATIENTS SUPPORTED WITH CONTINUOUS-FLOW LEFT VENTRICULAR ASIST DEVICES. Journal of the American College of Cardiology. 63:A890-A890.
-
2014Clinical Characteristics, Treatment Patterns and Outcomes of Hispanic Hypertensive Patients. Progress in Cardiovascular Diseases. 57:244-252.
-
2014Disparate Effects of Metabolically Healthy Obesity in Coronary Heart Disease and Heart Failure. Journal of the American College of Cardiology. 63:1079-1081.
-
2014Does Etiology of Heart Failure Predict Orthostatic Hypotension in Patents with Left Ventricular Assist Device?. Journal of Cardiac Failure. 20:S33-S33.
-
2014Effects of Left Ventricular Geometry and Obesity on Mortality in Women With Normal Ejection Fraction. American Journal of Cardiology. 113:877-880.
-
2014Effects of Obesity and Weight Changes on Cardiac and Vascular Structure and Function Does the Clinical Impact Carry Any Weight?. JACC: Heart Failure. 2:509-511.
-
2014Impact of Echocardiographic Left Ventricular Geometry on Clinical Prognosis. Progress in Cardiovascular Diseases. 57:3-9.
-
2014Regional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry. Journal of Heart and Lung Transplantation. 33:S72-S73.
-
2014Reply to Reciprocal Healing in Healthcare. The Ochsner Journal. 14:517-518.
-
2014The consummate clinician. Journal of Heart and Lung Transplantation. 33.
-
2013Bridge-to-Decision LVAD Support Using the Impella 5.0 Via a Right Subclavian Artery Approach. Journal of Heart and Lung Transplantation. 32:S281-S281.
-
2013EFFECT OF LOW DOSE DOPAMINE INFUSION ON RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE PATIENTS TREATED WITH INTRAVENOUS FUROSEMIDE. Journal of Investigative Medicine. 61:373-373.
-
2013Impact of Obesity and the Obesity Paradox on Prevalence and Prognosis in Heart Failure. JACC: Heart Failure. 1:93-102.
-
2013Transcatheter Potts shunt: An innovative IDEA. Journal of Heart and Lung Transplantation. 32:388-389.
-
2012Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach. Future Cardiology. 8:115-122.
-
2012Do BNP Levels and Prognostic Value Vary by Race/Ethnicity in Patients Hospitalized With Heart Failure?. Journal of Cardiac Failure. 18:S80-S81.
-
2012Exercise Training as Treatment of Depression in Heart Failure. Journal of the American College of Cardiology. 59:291-291.
-
2012Vasodilating Versus First-Generation beta-Blockers for Cardiovascular Protection. Postgraduate Medicine. 124:7-15.
-
2011Advances in mechanical circulatory support: Year in review. Journal of Heart and Lung Transplantation. 30:487-493.
-
2011Antihypertensive Therapy for Prehypertension Relationship With Cardiovascular Outcomes. Journal of the American Medical Association. 305:940-941.
-
2011Geographic variations of acute heart failure syndromes: The importance of clinical registries. American Heart Journal. 162:1-2.
-
2011Hypertension and Antihypertensive Therapy in Hispanics and Mexican Americans Living in the United States. Postgraduate Medicine. 123:46-57.
-
2011Impact of Exercise Training and Depression on Survival in Heart Failure Due to Coronary Heart Disease. American Journal of Cardiology. 107:64-68.
-
2011Impact of Obesity on Outcomes in Myocardial Infarction. Journal of the American College of Cardiology. 58:2651-2653.
-
2011Left Atrial Volume Index Predictive of Mortality Independent of Left Ventricular Geometry in a Large Clinical Cohort With Preserved Ejection Fraction. Mayo Clinic Proceedings. 86:730-737.
-
2011Metabolic Syndrome and Heart Failure-The Risk, Paradox, and Treatment. Current Hypertension Reports. 13:142-148.
-
2011Natriuretic Peptides as Markers of Cardiovascular Risk: The Story Continues. Mayo Clinic Proceedings. 86:1143-1145.
-
2011Progression from Concentric Left Ventricular Hypertrophy and Normal Ejection Fraction to Left Ventricular Dysfunction. American Journal of Cardiology. 108:992-996.
-
2011Pulmonary hypertension: the specialist opinion. INSUFICIENCIA CARDIACA. 6:65-79.
-
2011The Coalition to Reduce Racial and Ethnic Disparities in Cardiovascular Disease Outcomes (credo) Why credo Matters to Cardiologists. Journal of the American College of Cardiology. 57:245-252.
-
2011Weighing in on Obesity and the Obesity Paradox in Heart Failure. Journal of Cardiac Failure. 17:381-383.
-
2010Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the "Obesity Paradox". Mayo Clinic Proceedings. 85:605-608.
-
2010
-
2010METABOLIC INSIGHTS IN HEART FAILURE. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA. 39:92-96.
-
2010THE END-STAGE OF HEART FAILURES. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA. 39:174-179.
-
2010The Role of Omega-3 Fatty Acids in Primary Prevention of Coronary Artery Disease and in Atrial Fibrillation Is Controversial Reply. Journal of the American College of Cardiology. 55:411-412.
-
2009Advanced Heart Failure and Management Strategies. The Ochsner Journal. 9:227-233.
-
2009Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control. Cardiovascular Drugs and Therapy. 23:109-111.
-
2009Clinical Impact of Left Ventricular Hypertrophy and Implications for Regression. Progress in Cardiovascular Diseases. 52:153-167.
-
2009Dietary Intake of Nuts and Cardiovascular Prognosis. The Ochsner Journal. 9:32-36.
-
2009Disparate Effects of Obesity and Left Ventricular Geometry on Mortality in 8088 Elderly Patients with Preserved Systolic Function. Postgraduate Medicine. 121:119-125.
-
2009
-
2009Emerging diuretics for the treatment of heart failure. Expert Opinion on Emerging Drugs. 14:195-204.
-
2009Exercise Training and Heart Failure in Older Adults-Dismal Failure or Not Enough Exercise?. Journal of the American Geriatrics Society. 57:2148-2150.
-
2009High-density Lipoprotein Cholesterol Levels and Prognosis in Advanced Heart Failure. Journal of Heart and Lung Transplantation. 28:876-880.
-
2009Hypertension and Cardiac Failure in its Various Forms. Medical Clinics of North America. 93:665.
-
2009Impact of Left Atrial Volume Index and Left Ventricular Geometry on Mortality in Obese Versus Nonobese Elderly Patients With Preserved Ejection Fraction. Journal of the American College of Cardiology. 53:A238-A238.
-
2009Left Atrial Volume Index and Left Ventricular Geometry Independently Predict Mortality in 16,904 Elderly Patients With Preserved Ejection Fraction. Journal of the American College of Cardiology. 53:A273-A273.
-
2009Left Atrial Volume and Mortality Prediction: Does the Method of Indexing Matter?. Circulation. 120:S382-S382.
-
2009New Data on the Clinical Impact of Exercise Training, Fish Oils, and Statins in Heart Failure. Physician and Sportsmedicine. 37:22-28.
-
2009Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss. Journal of the American College of Cardiology. 53:1925-1932.
-
2009
-
2009Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. Journal of the American College of Cardiology. 54:585-594.
-
2009The Obesity Paradox in Coronary Heart Disease-Does Body Fat Complete the Puzzle?. Journal of the American College of Cardiology. 53:A227-A227.
-
2009The Obesity Paradox, Weight Loss, and Coronary Disease. American Journal of Medicine. 122:1106-1114.
-
2008Device therapy for heart failure - When and for whom?. American Journal of Cardiovascular Drugs. 8:147-153.
-
2008Fish Oil in Primary and Secondary Cardiovascular Prevention. The Ochsner Journal. 8:49-60.
-
2008Impact of Left Ventricular Geometry on Prognosis-A Review of Ochsner Studies. The Ochsner Journal. 8:11-17.
-
2008Left Ventricular Geometry Predicts Mortality in 26,216 Women with Preserved Systolic Function. Circulation. 118:S602-S603.
-
2008The eye as an indicator of heart failure in diabetic patients. Journal of the American College of Cardiology. 51:1579-1580.
-
2008The obesity paradox or vulnerability of the underweight - Response. Revista Española de Cardiología. 61:654-656.
-
2008The obesity paradox: Impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgraduate Medicine. 120:34-41.
-
2008Untangling the heavy cardiovascular burden of obesity. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE. 5:428-429.